What is the protocol for the dexamethasone (corticosteroid) suppression test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The dexamethasone suppression test protocol involves administering 1 mg of oral dexamethasone at 11 PM, followed by a blood draw for cortisol measurement between 8-9 AM the next morning, with normal results showing cortisol suppression to less than 1.8 μg/dL (50 nmol/L) 1.

Key Considerations

  • The test is used to assess the hypothalamic-pituitary-adrenal axis function and diagnose conditions like Cushing's syndrome.
  • Patients should avoid alcohol, stress, and medications that affect dexamethasone metabolism for at least one week before testing.
  • The test works because dexamethasone normally suppresses ACTH production from the pituitary, which reduces cortisol secretion.
  • Failure to suppress cortisol suggests conditions like Cushing's syndrome, depression, or alcoholism.

Protocol Details

  • For the standard overnight test, the patient takes 1 mg of oral dexamethasone at 11 PM.
  • A blood draw for cortisol measurement is taken between 8-9 AM the next morning.
  • Normal results show cortisol suppression to less than 1.8 μg/dL (50 nmol/L) 1.
  • Measuring dexamethasone concomitantly with cortisol can reduce the risk of false-positive results 1.

Special Considerations

  • False positive results may be seen with rapid absorption/malabsorption of dexamethasone, concomitant treatment with CYP3A4 inducers, or increased corticosteroid binding globulin (CBG) levels 1.
  • False negative results are less common, typically resulting from inhibition of dexamethasone metabolism by concomitant medications or decreased CBG and albumin levels 1.

Recent Guidelines

  • The most recent guidelines recommend using the overnight 1-mg dexamethasone suppression test as a diagnostic tool for Cushing's syndrome 1.
  • The guidelines also suggest measuring dexamethasone levels along with cortisol to improve test interpretability 1.

From the Research

Dexamethasone Suppression Test Protocol

The dexamethasone suppression test is a widely used screening tool for Cushing's syndrome, a condition characterized by excess cortisol production. The test protocol typically involves administering a low dose of dexamethasone, a synthetic corticosteroid, and measuring the subsequent cortisol levels in the blood or urine.

Test Procedure

  • The overnight 1-mg dexamethasone suppression test involves giving 1 mg of dexamethasone at midnight, and then measuring the plasma cortisol level at 8:00 the following morning 2.
  • The test can also be performed over a longer period, such as 24 or 48 hours, with multiple measurements of cortisol levels 3.
  • In some cases, a combined dexamethasone-CRH (corticotropin-releasing hormone) test may be used to distinguish Cushing's syndrome from pseudo-Cushing's states 4.

Interpretation of Results

  • A cortisol level above a certain threshold (e.g., 5 microg/dL) after dexamethasone administration may indicate Cushing's syndrome 2.
  • However, the sensitivity and specificity of the test can vary depending on the population being tested and the criteria used to define a positive result 2, 3.
  • The test may not be reliable in patients with mild or episodic Cushing's syndrome, as they may suppress cortisol production in response to dexamethasone 2.

Factors Affecting Test Results

  • Obesity is not a confounding factor in the 1-mg dexamethasone suppression test, as obese individuals suppress cortisol production similarly to non-obese individuals 5.
  • The dexamethasone-suppressed CRH test can differentiate mild Cushing's disease from normal physiology, but its value in patients with episodic hormonogenesis has not been tested 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.